Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF- prolylhydroxylase

M.A. Selak, S.M. Armour, E.D. MacKenzie, H. Boulahbel, D.G. Watson, K.D. Mansfield, Y. Pan, M.C. Simon, C.B. Thompson, E. Gottlieb

Research output: Contribution to journalArticlepeer-review

1335 Citations (Scopus)


Several mitochondrial proteins are tumor suppressors. These include succinate dehydrogenase (SDH) and fumarate hydratase, both enzymes of the tricarboxylic acid (TCA) cycle. However, to date, the mechanisms by which defects in the TCA cycle contribute to tumor formation have not been elucidated. Here we describe a mitochondrion-to-cytosol signaling pathway that links mitochondrial dysfunction to oncogenic events: succinate, which accumulates as a result of SDH inhibition, inhibits HIF-α prolyl hydroxylases in the cytosol, leading to stabilization and activation of HIF-1α. These results suggest a mechanistic link between SDH mutations and HIF-1α induction, providing an explanation for the highly vascular tumors that develop in the absence of VHL mutations.
Original languageEnglish
Pages (from-to)77-85
Number of pages9
JournalCancer Cell
Publication statusPublished - 2005


  • tricarboxylic acid (TCA) cycle
  • succinate dehydrogenase (SDH)
  • prolylhydroxylase


Dive into the research topics of 'Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF- prolylhydroxylase'. Together they form a unique fingerprint.

Cite this